Tempo Therapeutics, headquartered in San Diego, California, is pioneering a new era in tissue engineering biotechnology, using our proprietary MAP material science technology.

MAP (Microporous Annealed Particle) is a core technology that enables Tempo to create fully synthetic and precision engineered injectable materials that can modulate a patient’s own immune cells to drive biological responses.

Using MAP technology, we are building functional tissue and organs within patients to treat disease. Our mission is to use MAP technology to build material therapies enabling the future of medicine.

Tempo’s leading biosurgery products solve significant clinical challenges in patients undergoing abdominal laparotomy for surgical oncology, and patients with complex surgical sites from diabetic limb salvage and trauma. By building new vascular tissue in these patients, our products improve tissue strength and restore function – improving outcomes and saving lives. Tempo is also developing combination drug delivery, allogenic cell engraftment, and next-generation vaccine technologies.

Tempo is a team of dedicated scientists, physicians and engineers developing novel therapies based on MAP technology. We are actively engaged in building strategic relationships to access new therapeutic areas – with the goal of using tissue engineering to build better lives for patients in need.

Recognized as a Connect San Diego “cool company” in 2020